|
| | Publication Year | Title | Author(s) |
| 1 | 1-Sep-2023 | Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance. | Barraclough, Allison ; England, James T; Villa, Diego; Wight, Joel C ; Hapgood, Greg; Conn, Jason; Doo, Nicole Wong; Li, Eric Wenlong; Gilbertson, Michael; Shaw, Briony; Bishton, Mark J; Saeed, Malik; Ratnasingam, Sumita; Abeyakoon, Chathuri; Chong, Geoff; Wai, Shin Hnin; Ku, Matthew; Lee, Hui-Peng; Fleming, Kathryn; Tam, Constantine; Douglas, Genevieve ; Cheah, Chan Y; Ng, Zi Yun; Rolfe, Tukten; Mills, Anthony K; Hamad, Nada; Cashman, Helen; Gleeson, Mary; Narayana, Manjunath; Hawkes, Eliza A |
| 2 | May-2023 | Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study. | Manos, Kate ; Chong, Geoffrey ; Keane, Colm; Lee, Sze Ting ; Smith, Charmaine; Churilov, Leonid ; McKendrick, Joseph; Renwick, William; Blombery, Piers; Burgess, Melinda; Nelson, Niles Elizabeth; Fancourt, Tineke ; Hawking, Joanne; Lin, Wendi; Scott, Andrew M ; Barraclough, Allison ; Wight, Joel C ; Grigg, Andrew P ; Fong, Chun Yew ; Hawkes, Eliza A |
| 3 | Sep-2022 | Diffuse large B-cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. | Wight, Joel C ; Hamad, Nada; Campbell, Belinda A; Ku, Matthew; Lee, Kenneth; Rose, Hannah; Armytage, Tasman; Latimer, Maya; Lee, Hui-Peng; Lee, Sze Ting ; Dickinson, Michael; Khor, Richard ; Verner, Emma |
| 4 | 16-May-2022 | Toxicity associated with high-dose intravenous methotrexate for hematological malignancies. | Wight, Joel C ; Ku, Matthew; Garwood, Melissa; Carradice, Duncan; Lasica, Masa; Keamy, Louise; Hawkes, Eliza A ; Grigg, Andrew P |
| 5 | 16-Sep-2021 | Diffuse large B-cell lymphoma: A consensus practice statement from the Australasian Lymphoma Alliance. | Wight, Joel C ; Hamad, N; Campbell, B A; Ku, M; Lee, K; Rose, H; Armytage, T; Latimer, M; Lee, H P; Lee, Sze Ting ; Dickinson, M; Khor, Richard ; Verner, E |
| 6 | 8-Jul-2021 | Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma. | Wight, Joel C ; Wai, Shin Hnin; Shen, Edward; Lee, Sze Ting ; Berlangieri, Salvatore U ; Fancourt, Tineke ; Hawkes, Eliza A ; Hannah, Anthony; Leung, Teresa; Chong, Geoffrey |
| 7 | 1-Jan-2021 | Utility of clinical comprehensive genomic characterisation for diagnostic categorisation in patients presenting with hypocellular bone marrow failure syndromes. | Blombery, Piers; Fox, Lucy; Ryland, Georgina L; Thompson, Ella R; Lickiss, Jennifer; McBean, Michelle; Yerneni, Satwica; Hughes, David; Greenway, Anthea; Mechinaud, Francoise; Wood, Erica M; Lieschke, Graham J; Szer, Jeff; Barbaro, Pasquale; Roy, John; Wight, Joel C ; Lynch, Elly; Martyn, Melissa; Gaff, Clara; Ritchie, David |
| 8 | 18-Mar-2020 | EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity. | Gandhi, Maher K; Hoang, Thanh; Law, Soi C; Brosda, Sandra; O'Rourke, Kacey; Tobin, Joshua W D; Vari, Frank; Murigneux, Valentine; Fink, J Lynn; Gunawardana, Jay; Gould, Clare M; Oey, Harald; Bednarska, Karolina; Delecluse, Susanne; Trappe, Ralf Ulrich; de Long, Lilia Merida; Sabdia, Muhammed Bilal; Bhagat, Govind; Hapgood, Greg; Blyth, Emily; Clancy, Leighton E; Wight, Joel C ; Hawkes, Eliza A ; Rimsza, Lisa M; Maguire, Alanna; Bojarczuk, Kamil; Chapuy, Bjoern; Keane, Colm |
| 9 | 2019 | Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance. | Wight, Joel C ; Yue, Mimi; Keane, Colm; Johnston, Anna; Linton, Kim; Chin, Collin; Wai, Shin Hnin; Talaulikar, Dipti; Gasiorowski, Robin; Cheah, Chan Yoon; Gregory, Gareth P; Dickinson, Michael; Minson, Adrian; Coombes, Caitlin; Ku, Matthew; Lam, Stephanie; Hawkes, Eliza A |
| 10 | Dec-2018 | A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. | Schwarer, Anthony P ; Butler, Jason; Jackson, Kathryn; Beligaswatte, Ashanka; Martin, Louisa; Kennedy, Glen; Daniela, Zantomio; Lewis, Ian; Hiwase, Devendra; Wight, Joel C ; He, Simon ; Grigg, Andrew; Morris, Kirk; Mollee, Peter; Marlton, Paula |
| 11 | Oct-2018 | Correlation of mutation status and morphological changes in essential thrombocythaemia and myelofibrosis. | Chua, Chong Chyn ; Omerod, Amanda; Wight, Joel C ; Juneja, Surender; Zantomio, Daniela |
| 12 | 21-Jul-2018 | Dapsone safety in haematology patients: pathways to optimising Pneumocystis jirovecii pneumonia prophylaxis in haematology malignancy and transplant recipients. | Urbancic, Karen F ; Pisasale, D ; Wight, Joel C ; Trubiano, Jason |
| 13 | 2-May-2018 | Prognostic Markers in Core-Binding Factor AML and Improved Survival with Multiple Consolidation Cycles of Intermediate/High-dose Cytarabine. | Prabahran, Ashvind; Tacey, Mark A ; Fleming, Shaun; Wei, Andrew; Tate, Courtney; Marlton, Paula; Wight, Joel C ; Grigg, Andrew P ; Tuckfield, Annabel; Szer, Jeff; Ritchie, David; Chee, Lynette |
| 14 | 2018 | An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma. | Wight, Joel C ; Hawkes, Eliza A ; Berlangieri, Salvatore U ; Khor, Richard ; Grigg, Andrew P |
| 15 | 2018 | Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. | Wight, Joel C ; Chong, Geoffrey ; Grigg, Andrew P ; Hawkes, Eliza A |
| 16 | 14-Apr-2015 | Screening whole spine Magnetic Resonance Imaging (MRI) in multiple myeloma. | Wight, J ; Morris, E; Stillwell, A; Grant, B; Lai, H C; Irving, I |
Loading...
2
0
20
0
false